Electro-technology for pharmaceutical production.

Electro-technology for pharmaceutical production.

Company Membranines Tehnologios more than 15 years of experience in matters of innovative use electromembrane (electrodialysis) equipment in the pharmaceutical and chemical industry. In particular, in 1996, specialists have proposed a method for preparing 3 — (2,2,2-trimethylhydrazinium) propionate dihydrate with the method of electrodialysis. Electrodialysis process was carried out in a specially designed apparatus in which the circulating solution of 3 — (2,2,2-trimetigidraziny) methyl propionate bromide, alkali, and distilled water. A solution of starting material was subjected to alkaline hydrolysis efficiently, bromine ion is removed to form NaBr. The proposed method, tested on PAT Grindeks, Latvia,

Continue reading Electro-technology for pharmaceutical production.

Ural Pharmaceutical Cluster opened in Grozny outpatient dialysis center

Ural Pharmaceutical Cluster opened in the Chechen Republic of the modern center of outpatient dialysis.

The clinic was built entirely by private investors, members of the Ural Pharmaceutical Cluster. The project was prepared by the Ural clinic specialists, and it is fully equipped with equipment manufactured in the Sverdlovsk region.

For this center in Chechnya delivered 14 vehicles "artificial kidney", which are produced in Novoural'sk and installed water treatment system, the system of centralized distribution of concentrate electrodeionization systems, thermal disinfection, ventilation systems of production that are also produced in the Sverdlovsk region at the "Medsintez" .

Doctors, nurses and

Continue reading Ural Pharmaceutical Cluster opened in Grozny outpatient dialysis center

TPU provides exclusive training center for professionals in the pharmaceutical and biotechnology

The first in Russia Tomsk Polytechnic University begins to prepare exclusive specialists for the pharmaceutical and biotech industries. The new master's program "Engineering in the biotech and pharmaceutical industry" will open in the scientific and educational center "TPU-R-Farm" in 2012, the Center created on the basis of the Department of Physical and Analytical Chemistry, Institute of Natural Resources in cooperation with Russia's largest pharmaceutical company "R-Pharm. "

To date, a draft curriculum master program "Engineering in the biotechnology and pharmaceutical industries." The program is formed with the competences proposed by JSC "R-Pharm". It is the knowledge that

Continue reading TPU provides exclusive training center for professionals in the pharmaceutical and biotechnology

TSU and FNPC Altai started to produce unique raw materials for the pharmaceutical industry

 Photo source:flexcom.ru

Tomsk State University in cooperation with Biisk Federal Scientific and Production Center "Altai" launched a joint innovation project. It is aimed at the development of domestic technology and production of raw materials — 2-methylimidazole necessary for anti-infective drugs that are synthesized from glyoxal. The size of investment in the production of 150 million rubles.

«C as long as in 2009 on the basis of our development was started the production of glyoxal in Tomsk, we have the opportunity to initiate similar projects, — says Alexey Knyazev, head of the Laboratory of catalytic research TSU. -We are

Continue reading TSU and FNPC Altai started to produce unique raw materials for the pharmaceutical industry

The agreement on the joint development and production of innovative and foreign drugs

JSC "Chemical Diversity Research Institute" (CDRI) Group of the Center of High Technologies "KhimRar" (Khimki, Moscow region.) And St. Petersburg State Chemical-Pharmaceutical Academy (SPCPA) signed an agreement on cooperation in the development and manufacture of import substitution and innovative medicines. The objectives of the agreement are defined in accordance with "The strategy of the pharmaceutical industry of the Russian Federation up to 2020". The objectives of the Agreement: • Development of innovative potential SPCPA. • Attraction of budgetary and extra-budgetary investment and implementation of Government programs in the fields of pharmaceuticals and higher education. • Increase the level of professional

Continue reading The agreement on the joint development and production of innovative and foreign drugs

The increase in production glassware for pharmaceutical purposes!

The analysis of Russian domestic production, conducted by «VVS» (VladVneshServis) following two quarters of 2011, the market for glass OKP code 26.15.23 (glass dishes for laboratory, hygienic or pharmaceutical purposes; vials made of glass) increased compared to the same period last year by 32%! The volume of Russian domestic production for the 2nd quarter reached 728.9 million units. A leading manufacturer of glassware for laboratory, hygienic or pharmaceutical purposes Orel region. The increase in production in the region was more than 70% compared to last year’s figure for the same period. The share of the region is 0.25%.

Want

Continue reading The increase in production glassware for pharmaceutical purposes!

Review created in Russian pharmaceutical clusters

The article discussed in detail created now pharmaceutical clusters: the site "Neudorf" and "Novo-Orlovsky" in St. Petersburg, "Novosyolki" in Yaroslavl region, a center of innovative biotechnology and pharmaceuticals "Park of the active molecules" and the industrial park "Vorsino" in Kaluga region, Technopark "Pharmaceuticals" in the Stavropol region, biofarmklaster "North" in Dolgoprudnom.

The main task — to get away from dependence on imports and to create their own laboratories and factories for the development and production of effective and safe drugs, and in cooperation with leading manufacturers, and completely unique Russian design.

 Photo source:nanonewsnet.ru

Molecular map of the

Continue reading Review created in Russian pharmaceutical clusters

TSU and FNPC Altai started to produce unique raw materials for the pharmaceutical industry

 Photo source:flexcom.ru

Tomsk State University in cooperation with Biisk Federal Scientific and Production Center "Altai" launched a joint innovation project. It is aimed at the development of domestic technology and production of raw materials — 2-methylimidazole necessary for anti-infective drugs that are synthesized from glyoxal. The size of investment in the production of 150 million rubles.

«C as long as in 2009 on the basis of our development was started the production of glyoxal in Tomsk, we have the opportunity to initiate similar projects, — says Alexey Knyazev, head of the Laboratory of catalytic research TSU. -We are

Continue reading TSU and FNPC Altai started to produce unique raw materials for the pharmaceutical industry

Laid the first stone of a pharmaceutical plant Novartis

In the Maritime region in the "Novo-Orlovsky" special economic zone of St. Petersburg, laid the first stone of the first factory in the Russian group of companies "Novartis".

The ceremony was attended by the Governor of St. Petersburg Valentina Matvienko, the Minister of Economic Development Elvira Nabiullina, CEO of Novartis International AG Joseph Jimenez.

The project company "Novartis Neva" — one of the most important elements of the formation of pharmaceutical cluster in St. Petersburg. It combines science and production.

"A year ago at the St. Petersburg Economic Forum, we signed the first agreements with

Continue reading Laid the first stone of a pharmaceutical plant Novartis

The agreement on the joint development and production of innovative and foreign drugs

JSC "Chemical Diversity Research Institute" (CDRI) Group of the Center of High Technologies "KhimRar" (Khimki, Moscow region.) And St. Petersburg State Chemical-Pharmaceutical Academy (SPCPA) signed an agreement on cooperation in the development and manufacture of import substitution and innovative medicines. The objectives of the agreement are defined in accordance with "The strategy of the pharmaceutical industry of the Russian Federation up to 2020". The objectives of the Agreement: • Development of innovative potential SPCPA. • Attraction of budgetary and extra-budgetary investment and implementation of Government programs in the fields of pharmaceuticals and higher education. • Increase the level of professional

Continue reading The agreement on the joint development and production of innovative and foreign drugs

SQL - 16 | 0,829 сек. | 7.27 МБ